Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis

Journal of Lipid Research

Volumn 48, Issue 7, 2007, Pages 1571-1580

  Fergani, Anissa ^a,b   Oudart, Hugues ^c   De Aguilar, Jose Luis Gonzalez ^a,b   Fricker, Bastien ^a,b   René, Frédérique ^a,b   Hocquette, Jean François ^d   Meininger, Vincent ^e   Dupuis, Luc ^a,b   Loeffler, Jean Philippe ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c CNRS   (France)

^d UMR1213 HERBIVORES   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

High density lipoprotein; Intestinal absorption; Liver metabolism; Low density lipoprotein; Motor neuron; Neurodegeneration; Plasma lipoproteins; Skeletal muscle

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; LIPID; LIPOPROTEIN; TRIACYLGLYCEROL;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL ABSORPTION; GENE EXPRESSION; HYPOLIPEMIA; LIPID ABSORPTION; LIPID BLOOD LEVEL; LIPID DIET; LIPID LIVER LEVEL; LIPID METABOLISM; METABOLIC CLEARANCE RATE; MOUSE; NEUROPROTECTION; NONHUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ENERGY METABOLISM; FEMALE; GENE EXPRESSION PROFILING; INTESTINAL ABSORPTION; LIPIDS; LIVER; MICE; MICE, TRANSGENIC; MUSCLE, SKELETAL; SUPEROXIDE DISMUTASE; TRIGLYCERIDES;

EID: 34548145662     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M700017-JLR200     Document Type: Article

References (39)

1. Pedersen, W. A., and E. R. Flynn. 2004. Insulin resistance contributes to aberrant stress responses in the Tg2576 mouse model of Alzheimer's disease. Neurobiol. Dis. 17: 500-506.
2. Pedersen, W. A., P. J. McMillan, J. J. Kulstad, J. B. Leverenz, S. Craft, and G. R. Haynatzki. 2006. Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice. Exp. Neurol. 199: 265-273.
3. Bjorkqvist, M., M. Fex, E. Renstrom, N. Wierup, A. Petersen, J. Gil, K. Bacos, N. Popovic, J. Y. Li, F. Sundler, et al. 2005. The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient beta-cell mass and exocytosis. Hum. Mol. Genet. 14: 565-574.
4. Fain, J. N., N. A. Del Mar, C. A. Meade, A. Reiner, and D. Goldowitz. 2001. Abnormalities in the functioning of adipocytes from R6/2 mice that are transgenic for the Huntington's disease mutation. Hum. Mol. Genet. 10: 145-152.
5. Hurlbert, M. S., W. Zhou, C. Wasmeier, F. G. Kaddis, J. C. Hutton, and C. R. Freed. 1999. Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes. Diabetes. 48: 649-651.
6. Dupuis, L., H. Oudart, F. Rene, J. L. Gonzalez de Aguilar, and J. P. Loeffler. 2004. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc. Natl. Acad. Sci. USA. 101: 11159-11164.
7. Weydt, P., V. V. Pineda, A. E. Torrence, R. T. Libby, T. F. Satterfield, E. R. Lazarowski, M. L. Gilbert, G. J. Morton, T. K. Bammler, A. D. Strand, et al. 2006. Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration. Cell Metab. 4: 349-362.
8. Pasinelli, P., and R. H. Brown. 2006. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci. 7: 710-723.
9. Gonzalez de Aguilar, J. L., A. Echaniz-Laguna, A. Fergani, F. René, V. Meininger, J. P. Loeffler, and L. Dupuis. 2007. Amyotrophic lateral sclerosis: all roads lead to Rome. J. Neurochem. 101: 1153-1160.
10. Ripps, M. E., G. W. Huntley, P. R. Hof, J. H. Morrison, and J. W. Gordon. 1995. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 92: 689-693.
11. Gurney, M. E., H. Pu, A. Y. Chiu, M. C. Dal Canto, C. Y. Polchow, D. D. Alexander, J. Caliendo, A. Hentati, Y. W. Kwon, and H. X. Deng. 1994. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 264: 1772-1775.
12. Wong, P. C., C. A. Pardo, D. R. Borchelt, M. K. Lee, N. G. Copeland, N. A. Jenkins, S. S. Sisodia, D. W. Cleveland, and D. L. Price. 1995. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron. 14: 1105-1116.
13. Rosen, D. R., T. Siddique, D. Patterson, D. A. Figlewicz, P. Sapp, A. Hentati, D. Donaldson, J. Goto, J. P. O'Regan, H. X. Deng, et al. 1993. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 362: 59-62.
14. Clement, A. M., M. D. Nguyen, E. A. Roberts, M. L. Garcia, S. Boillee, M. Rule, A. P. McMahon, W. Doucette, D. Siwek, R. J. Ferrante, et al. 2003. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science. 302: 113-117.
15. Boillee, S., K. Yamanaka, C. S. Lobsiger, N. G. Copeland, N. A. Jenkins, G. Kassiotis, G. Kollias, and D. W. Cleveland. 2006. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 312: 1389-1392.
16. Dupuis, L., F. di Scala, F. Rene, M. de Tapia, H. Oudart, P. F. Pradat, V. Meininger, and J. P. Loeffler. 2003. Up-regulation of mitochondrial uncoupling protein 3 reveals an early muscular metabolic defect in amyotrophic lateral sclerosis. FASEB J. 17: 2091-2093.
17. Desport, J. C., P. M. Preux, L. Magy, Y. Boirie, J. M. Vallat, B. Beaufrere, and P. Couratier. 2001. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am. J. Clin. Nutr. 74: 328-334.
18. Kasarskis, E. J., S. Berryman, J. G. Vanderleest, A. R. Schneider, and C. J. McClain. 1996. Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death. Am. J. Clin. Nutr. 63: 130-137.
19. Gonzalez de Aguilar, J. L., L. Dupuis, H. Oudart, and J. P. Loeffler. 2005. The metabolic hypothesis in amyotrophic lateral sclerosis: insights from mutant Cu/Zn-superoxide dismutase mice. Biomed. Pharmacother. 59: 190-196.
20. Mattson, M. P., R. G. Cutler, and S. Camandola. 2007. Energy intake and amyotrophic lateral sclerosis. Neuromolecular Med. 9: 17-20.
21. Pedersen, W. A., and M. P. Mattson. 1999. No benefit of dietary restriction on disease onset or progression in amyotrophic lateral sclerosis Cu/Zn-superoxide dismutase mutant mice. Brain Res. 833: 117-120.
22. Habold, C., C. Foltzer-Jourdainne, Y. Le Maho, J. H. Lignot, and H. Oudart. 2005. Intestinal gluconeogenesis and glucose transport according to body fuel availability in rats. J. Physiol. 566: 575-586.
23. Hocquette, J. F., B. Graulet, and T. Olivecrona. 1998. Lipoprotein lipase activity and mRNA levels in bovine tissues. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 121: 201-212.
24. Toepfer, M., C. Folwaczny, A. Klauser, R. L. Riepl, W. Muller-Felber, and D. Pongratz. 1999. Gastrointestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 1: 15-19.
25. Eberle, D., B. Hegarty, P. Bossard, P. Ferre, and F. Foufelle. 2004. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie. 86: 839-848.
26. Russell, D. W. 2003. The enzymes, regulation, and genetics of bile acid synthesis. Annu. Rev. Biochem. 72: 137-174.
27. Desport, J. C., F. Torny, M. Lacoste, P. M. Preux, and P. Couratier. 2005. Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. Neurodegener Dis. 2: 202-207.
28. Echaniz-Laguna, A., J. Zoll, E. Ponsot, B. N'guessan, C. Tranchant, J. P. Loeffler, and E. Lampert. 2006. Muscular mitochondrial function in amyotrophic lateral sclerosis is progressively altered as the disease develops: a temporal study in man. Exp. Neurol. 198: 25-30.
29. Vielhaber, S., K. Winkler, E. Kirches, D. Kunz, M. Buchner, H. Feistner, C. E. Elger, A. C. Ludolph, M. W. Riepe, and W. S. Kunz. 1999. Visualization of defective mitochondrial function in skeletal muscle fibers of patients with sporadic amyotrophic lateral sclerosis. J. Neurol. Sci. 169: 133-139.
30. Vielhaber, S., D. Kunz, K. Winkler, F. R. Wiedemann, E. Kirches, H. Feistner, H. J. Heinze, C. E. Elger, W. Schubert, and W. S. Kunz. 2000. Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis. Brain. 123: 1339-1348.
31. Krasnianski, A., M. Deschauer, S. Neudecker, F. N. Gellerich, T. Muller, B. G. Schoser, M. Krasnianski, and S. Zierz. 2005. Mitochondrial changes in skeletal muscle in amyotrophic lateral sclerosis and other neurogenic atrophies. Brain. 128: 1870-1876.
32. Espirito Santo, S. M., P. C. Rensen, J. R. Goudriaan, A. Bensadoun, N. Bovenschen, P. J. Voshol, L. M. Havekes, and B. J. van Vlijmen. 2005. Triglyceride-rich lipoprotein metabolism in unique VLDL receptor, LDL receptor, and LRP triple-deficient mice. J. Lipid Res. 46: 1097-1102.
33. Goudriaan, J. R., S. M. Espirito Santo, P. J. Voshol, B. Teusink, K. W. van Dijk, B. J. van Vlijmen, J. A. Romijn, L. M. Havekes, and P. C. Rensen. 2004. The VLDL receptor plays a major role in chylomicron metabolism by enhancing LPL-mediated triglyceride hydrolysis. J. Lipid Res. 45: 1475-1481.
34. Yagyu, H., E. P. Lutz, Y. Kako, S. Marks, Y. Hu, S. Y. Choi, A. Bensadoun, and I. J. Goldberg. 2002. Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency. J. Biol. Chem. 277: 10037-10043.
35. Drover, V. A., M. Ajmal, F. Nassir, N. O. Davidson, A. M. Nauli, D. Sahoo, P. Tso, and N. A. Abumrad. 2005. CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood. J. Clin. Invest. 115: 1290-1297.
36. Ibrahimi, A., A. Bonen, W. D. Blinn, T. Hajri, X. Li, K. Zhong, R. Cameron, and N. A. Abumrad. 1999. Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin. J. Biol. Chem. 274: 26761-26766.
37. Miller, T. M., S. H. Kim, K. Yamanaka, M. Hester, P. Umapathi, H. Arnson, L. Rizo, J. R. Mendell, F. H. Gage, D. W. Cleveland, et al. 2006. Gene transfer demonstrates that muscle is not a primary target for non-cell autonomous toxicity in familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 103: 19546-19551.
38. Maswood, N., J. Young, E. Tilmont, Z. Zhang, D. M. Gash, G. A. Gerhardt, R. Grondin, G. S. Roth, J. Mattison, M. A. Lane, et al. 2004. Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease. Proc. Natl. Acad. Sci. USA. 101: 18171-18176.
39. Duan, W., Z. Guo, H. Jiang, M. Ware, X. J. Li, and M. P. Mattson. 2003. Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice. Proc. Natl. Acad. Sci. USA. 100: 2911-2916.